Article
Pharma giant plans to cash in on 'Ozempic face' craze with fillers
Rating:
0.0
Views:
23
Likes:
1
Library:
1
Flemming Ornskov, the CEO of Galderma, said that the Ozempic face phenomenon could be a boost for its fillers business.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value